Related Experiment Videos
Macrophage infiltration and angiogenesis in human malignancy
Helen Knowles1, Russell Leek, Adrian L Harris
1Cancer Research UK, Molecular Oncology Laboratories, Weatherall Institute of Molecular Medicine, Oxford OX3 9DU, UK.
Novartis Foundation Symposium
|March 19, 2004
Summary
Tumor hypoxia is linked to poor outcomes. High levels of hypoxia-inducible factor-2 alpha (HIF-2alpha) in tumor-associated macrophages are an independent predictor of poor prognosis, offering potential therapeutic targets.
Area of Science:
- Oncology
- Immunology
- Molecular Biology
Background:
- Human tumors exhibit hypoxia, contrasting with normal tissues.
- Tumor hypoxia correlates with adverse outcomes across various treatments.
- Hypoxia-inducible factors (HIF-1, -2) regulate gene transcription in response to low oxygen.
Purpose of the Study:
- To investigate the role of HIF-2alpha in tumor-associated macrophages (TAMs).
- To determine if macrophage HIF-2alpha levels are prognostic in cancer patients.
Main Methods:
- Comparative analysis of HIF-2alpha expression in TAMs versus normal macrophages and tumor cells.
- Assessment of HIF-2alpha as an independent prognostic factor.
Main Results:
- TAMs express significantly higher levels of HIF-2alpha compared to normal macrophages and tumor cells.
- Elevated macrophage HIF-2alpha is an independent prognostic indicator of poor patient outcomes.
- Monocyte differentiation into macrophages increases basal HIF-2alpha and alters hypoxia-responsive gene expression.
Conclusions:
- Macrophage HIF-2alpha upregulation, potentially influenced by inflammation and hypoxia, contributes to tumor progression.
- The hypoxia-responsive gene program in macrophages promotes angiogenesis and the tumor microenvironment.
- Targeting macrophage HIF-2alpha presents a potential therapeutic strategy for cancer treatment.